葛根素注射液与输液配伍的稳定性考察

目的　用正交法考察葛根素与 5 %葡萄糖注射液、0 9%氯化钠注射液、葡萄糖氯化钠注射液输液配伍后的稳定性。方法　用正交设计法 ,以葛根素的稳定性为考察指标 ,以浓度、温度、时间、输液种类为可变因素 ,选用L9(34)表进行实验 ,用紫外分光光度法测定其含量。结果　浓度、温度、时间、输液种类对葛根素的稳定性未产生显著性差异。结论　在低温 (4±1℃ )、常温 (17± 1℃ )、高温 (37± 1℃ )下 ,葛根素注射液与各输液均可配伍使用。     

排石灵片的制备和质量标准研究

目的：制备排石灵片并建立其质量控制方法。方法：以槲寄生、木通、泽泻、白茅根、车前子、牛膝、赤芍、延胡索、三棱、王不留行为主药制备排石灵片，用HPLC汉对芍药苷作含量测定，流动相为甲醇：水=28：72；流速：1．0mL．min^-1；紫外检测波长230nm；结果：芍药苷的平均回收率为98．4％，RSD为1．6％，且方法的稳定性与精密度实验的RSD均小于3％。结论：该制剂的制备工艺，质量可控且稳定。以XHPLC对气含量进行测定，方法简便、准确、重现性好。     

Clinical Analysis of 57 Patients with Ovarian Dysgerminoma

Objective  Ovarian dysgerminoma is an uncommon ovarian malignancy, Its clinicai features are special and there are many factors affecting its prognosis. If treated properly, the patient can be cured. Otherwise it may endanger the patient’s life. The aim of this study is to investigate the clinical features and factors related to prognosis of ovarian dysgerminoma. Methods  Data from 57 patients with pure ovarian dysgerminoma were analyzed retrospectively. The patients were admitted to the Cancer Center, Sun Yat-sen University from January 1.1964 to December 31, 2000. Results  The main clinical features were abdominal mass (56.1% ), abdominal pain (21.1% ), abdominal swelling (17.5%.), vaginal bleeding (5.3% )and genital tract abnormalities (5.3%). Twenty-six patients had stage I diseases, 8 stage II.9 stage III.1 stage IV and 13 recurrent and persistent diseases. The uterus was involved in 41.2% of patients with stage II -III diseases. Combined modality was given to 52 cases and a single-method treatment to 5 cases. The total overall 5 and 10-year survival rates for stages I-IV was 80.1 % and 70.0% respectively. The 5-year survival rate for stage I was 100%, stage II 55.2%. stage III 55.6% and stage IV 0%; for recurrent and persistent diseases, 72.7%. The stage I group of 12 patients. received adnexectomy and 14 patients underwent hysterectomy and adnexa removal. There was no significant difference between the 5 and 10-year survival rates (all 100%). Of the 23 patients in the stage I group to whom oniy chemotherapy was given after operation, 19 cases received 3 or more courses and were well without recurrence; 4 patients received only one course and one of them recurred 21 months after the operation. In the group of stages II and III cases, the 5-year survival rate was 86.7% for those whose chemotherapy courses were 3≥ 4 and 25.0% for patients who received less than 4 courses of chemotherapy (P<0.05). Conclusions  The prognosis of ovarian dysgerminoma is closely related to the disease stage and treatment modality. A fertility-preserving operation can be considered in early -staged patients, but caution needs to be exercised in the middle to late staged cases. Good results can be achieved with an operation-based combined modality in recurrent patients.     

216例恶性阻塞性黄疸患者手术疗效的因素分析

目的 探讨影响恶性阻塞性黄疸临床治疗的预后因素。方法 对１９９０年１月～１９９７年１２月２１６例恶性阻塞性黄疸手术患者的１７种临床指标进行分析。结果 １７３例（８０．１％）手术后１个月存活,发生并发症８１例,发生率３７．５％。台术者胆管炎、胆瘘、出血、肾功能衰竭等并发症均高于姑息术者,差异均有显著性（Ｐ〈０．０１）;１月生存率和术后并发症发生率与ＡＳＡ分级、黄疸持续的时间等有明显关系（Ｐ〈０．０１     

龙参颗粒的质量标准研究

目的:为龙参颗粒提供方便可行的质量控制方法。方法:采用薄层色谱法进行定性鉴别;用HPLC法对成品中苦参碱进行含量测定。结果:薄层层析可成功鉴别出当归和黄芪药材;Hypersil NH_2,色谱柱(4.6mm×200mm,5μm);柱温:25℃;流动相:乙腈-0.02mol/L磷酸二氢钠(82:18);流速:1mL/min;检测波长:215nm。加样回样率为97.70％,RSD为1.56％。结论:本实验方法基本可控制龙参颗粒的质量。     

胆囊腺瘤-腺癌中的DNA含量和基因表达

目的 研究胆囊腺瘤从增殖到恶变中腺上皮细胞的增殖变化和基因表达。方法PCR-RFLP法测定APC、ras基因突变,ABC免疫化学组织染色法测定p53蛋白表达。用TJTY-300全自动图像分析仪测定胆囊上皮细胞核异型性和DNA含量。结果 上皮细胞核异型性和DNA含量在胆囊腺瘤-腺癌过程中逐渐增加。胆囊腺瘤中异倍体比例与腺瘤的大小有明显的关系,直径≥1cm异倍体显著增加(P<0.05)。在胆囊腺瘤-腺癌过程中可检测到APC基因和RAS基因突变。P53蛋白在这一过程中不表达。结论 胆囊腺瘤-腺癌的过程是胆囊癌发生中一条重要的途径。当胆囊腺瘤直径≥1cm时具有明显的癌变潜能。其分子改变机制与胆囊上皮不典型增生-原位癌途径不同。     

住院精神病患者滥用镇静催眠药物倾向

目的:调查我院住院精神病患者镇静催眠药物使用情况.并对相关因素进行分析.方法:通过对591例住院精神病患者的病历进行回顾性调查,获取相关资料并进行分析.结果:住院精神病患者应用镇静催眠药物主要集中在40～49岁,住院时间≤5年,且女性相对用药率明显高于男性.结论:镇静催眠药物在住院精神病患者中的滥用倾向与患者的性别、年龄、住院时间及医师的工作情况有关.     

双黄连粉针剂加蒙脱石治疗婴幼儿秋季腹泻的疗效观察

目的: 观察双黄连粉针剂加蒙脱石口服治疗婴幼儿秋季腹泻的疗效.方法: 双黄连粉针剂加蒙脱石口服治疗102例秋季腹泻患儿,并与单用蒙脱石或双黄连组相比较.结果: 治疗组总有效率达92.1%,病程明显缩短(4.52±0.56)d;而单用蒙脱石或双黄连组有效率分别为67.4%,60.2%;病程分别为(5.90±0.72)d,(6.15±0.92)d,联合用药组与单用蒙脱石或双黄连组相比较,总有效率及病程均有显著性差异(P＜0.01).结论: 双黄连加蒙脱石治疗婴幼儿秋季腹泻疗效好,可提高治愈率,缩短病程,是较为安全而有效的药物.